{"nct_id":"NCT00229710","title":"GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes","status":"TERMINATED","status_verified_date":"2010-11","start_date":"2005-02","start_date_type":null,"primary_completion_date":"2006-12","primary_completion_date_type":"ACTUAL","completion_date":"2006-12","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AZN"]}